| Literature DB >> 33218264 |
Bat-Chen Tamim-Yecheskel1, Milana Fraiberg1, Kamilya Kokabi1, Saskia Freud1, Oren Shatz1, Letizia Marvaldi1, Nemanja Subic1, Ori Brenner2, Michael Tsoory2, Raya Eilam-Altstadter2, Inbal Biton2, Alon Savidor3, Nili Dezorella4, Gali Heimer5,6, Christian Behrends7, Bruria Ben-Zeev5,6, Zvulun Elazar1.
Abstract
Mutations in the coding sequence of human TECPR2 were recently linked to spastic paraplegia type 49 (SPG49), a hereditary neurodegenerative disorder involving intellectual disability, autonomic-sensory neuropathy, chronic respiratory disease and decreased pain sensitivity. Here, we report the generation of a novel CRISPR-Cas9 tecpr2 knockout (tecpr2-/-) mouse that exhibits behavioral pathologies observed in SPG49 patients. tecpr2-/- mice develop neurodegenerative patterns in an age-dependent manner, manifested predominantly as neuroaxonal dystrophy in the gracile (GrN) and cuneate nuclei (CuN) of the medulla oblongata in the brainstem and dorsal white matter column of the spinal cord. Age-dependent correlation with accumulation of autophagosomes suggests compromised targeting to lysosome. Taken together, our findings establish the tecpr2 knockout mouse as a potential model for SPG49 and ascribe a new role to TECPR2 in macroautophagy/autophagy-related neurodegenerative disorders.Entities:
Keywords: Autophagy; SPG49; TECPR2; axonal dystrophy; lysosome; neurodegeneration
Mesh:
Substances:
Year: 2020 PMID: 33218264 PMCID: PMC8526015 DOI: 10.1080/15548627.2020.1852724
Source DB: PubMed Journal: Autophagy ISSN: 1554-8627 Impact factor: 16.016